Aryl receptor modulators and methods of making and using the same
Grant
US12577256B2
Kind: B2
Mar 17, 2026
Assignee
Nogra Pharma Limited
Inventors
Francesca Viti, Salvatore Bellinvia, Salvatore Demartis
Abstract
The present invention is generally directed towards compounds capable of binding the aryl hydrocarbon receptor and modulating its activity, methods of treating inflammatory conditions such as Crohn's disease using such compounds, and pharmaceutical compositions comprising such compounds. Also provided are methods of increasing levels of IL-22 in a subject and/or decreasing levels of IFN-7 in a subject.
CPC Classifications
C07D 495/14
Filing Date
2024-05-07
Application No.
18656965
Claims
6